Corbus Pharmaceuticals Holdings (CRBP) Non-cash Items (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Non-cash Items of $371000.0 in Q4 2025, up 10779.77% quarter-over-quarter from $3410.0 in Q3 2025, and down 57.89% on a YoY basis from $881000.0 in Q4 2024.
Corbus Pharmaceuticals Holdings (CRBP) Non-cash Items (2014 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Non-cash Items history runs 12 years deep, the most recent figure standing at $371000.0 for Q4 2025.
- In Q4 2025, Non-cash Items fell 57.89% year-over-year to $371000.0; the TTM figure through Dec 2025 stood at $371000.0 (down 57.89% YoY), while the FY2025 annual figure was $371000.0, down 57.89% from the prior year.
- Non-cash Items was $371000.0 for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $3410.0 in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $38.8 million in Q3 2021 to a low of $312.0 in Q2 2025.
- Historically, Non-cash Items has averaged $12.6 million across 5 years, with a median of $10.6 million in 2022.
- The sharpest annual moves came in 2021 and 2025: Non-cash Items soared 157.42% in 2021, then slumped 99.92% in 2025.
- A 5-year view of Non-cash Items shows it stood at $9.0 million in 2021, then advanced by 24.25% to $11.2 million in 2022, then surged by 80.57% to $20.2 million in 2023, then tumbled by 95.64% to $881000.0 in 2024, then slumped by 57.89% to $371000.0 in 2025.
- The last three Non-cash Items figures came in at $371000.0 (Q4 2025), $3410.0 (Q3 2025), and $312.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 371,000.00 |
| Dec 31, 2025 | 371,000.00 |
| Sep 30, 2025 | 3,410.00 |
| Sep 30, 2025 | 3,410.00 |
| Jun 30, 2025 | 312.00 |
| Jun 30, 2025 | 312.00 |
| Mar 31, 2025 | 451,340.00 |
| Mar 31, 2025 | 451,340.00 |
| Dec 31, 2024 | 881,000.00 |
| Dec 31, 2024 | 881,000.00 |
| Sep 30, 2024 | 389,369.00 |
| Sep 30, 2024 | 389,369.00 |
| Jun 30, 2024 | 370,025.00 |
| Jun 30, 2024 | 370,025.00 |
| Mar 31, 2024 | 432,919.00 |
| Mar 31, 2024 | 432,919.00 |
| Dec 31, 2023 | 20.22 Mn |
| Dec 31, 2023 | 20.22 Mn |
| Sep 30, 2023 | 20.82 Mn |
| Sep 30, 2023 | 20.82 Mn |